Loading...
XSHE
002923
Market cap651mUSD
Dec 05, Last price  
13.75CNY
1D
-0.87%
1Q
-1.72%
IPO
67.20%
Name

Zhuhai Rundu Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002923 chart
P/E
115.46
P/S
3.89
EPS
0.12
Div Yield, %
1.45%
Shrs. gr., 5y
0.09%
Rev. gr., 5y
-2.76%
Revenues
1.18b
-8.48%
311,179,689361,933,893434,131,304523,598,200577,942,780651,862,100779,421,0161,043,860,4651,359,908,2951,252,630,8361,189,926,8671,372,233,9171,291,887,1421,182,362,768
Net income
40m
-40.38%
32,211,69356,596,22859,359,21359,519,86071,165,38287,465,79890,652,611106,844,362118,896,727135,862,411139,766,332155,476,93666,898,61739,883,176
CFO
211m
+22.30%
33,710,09170,013,89831,674,10058,011,47650,138,96794,069,92257,952,639159,043,847151,299,880250,346,177205,906,013135,007,685172,679,270211,187,476
Dividend
May 31, 20240.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.
IPO date
Jan 05, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT